株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

造影剤の世界市場 - 2022年までの予測:ヨード、ガドリニウム、バリウム、マイクロバブル

Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 259150
出版日 ページ情報 英文 178 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.84円で換算しております。
Back to Top
造影剤の世界市場 - 2022年までの予測:ヨード、ガドリニウム、バリウム、マイクロバブル Contrast Media/Contrast Agents Market by Type (Iodinated, Gadolinium, Barium, Microbubble) Modality (X-ray, CT, MRI, Ultrasound) Application (Radiology, Interventional Radiology, Interventional Cardiology) & by Indication - Global Forecast to 2022
出版日: 2017年11月23日 ページ情報: 英文 178 Pages
概要

世界の造影剤市場は、2017年の45億7000万米ドルから、2022年までに55億3000万米ドルまで拡大すると見られています。市場は、2017年〜2022年のCAGR (複合年間成長率) で、3.9%の成長が予測されています。

当レポートでは、世界の造影剤市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 造影剤:市場概要
  • アジア太平洋地域の造影剤市場:種類別
  • 地域別スナップショット:造影剤市場
  • 世界の造影剤市場:適応別
  • 世界の造影剤市場:モダリティ別

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題

第6章 パイプライン評価

  • イントロダクション
  • 造影剤による臨床試験
  • 製品パイプライン

第7章 造影剤の世界市場:種類別

  • イントロダクション
  • ヨード造影剤
  • ガドリニウム造影剤
  • マイクロバブル造影剤
  • バリウム造影剤

第8章 造影剤の世界市場:モダリティ別

  • イントロダクション
  • X線/CT
  • MRI
  • 超音波

第9章 造影剤の世界市場:適応別

  • イントロダクション
  • 心血管疾患
  • 胃腸疾患
  • 筋骨格系疾患
  • 神経疾患
  • 腎臓疾患

第10章 造影剤の世界市場:投与経路別

  • イントロダクション
  • 血管内
  • 経口
  • 直腸
  • その他

第11章 造影剤の世界市場:応用別

  • イントロダクション
  • 放射線科
  • IVR
  • IVC

第12章 造影剤の世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他

第13章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合シナリオ

第14章 企業プロファイル

  • GE HEALTHCARE
  • BAYER
  • BRACCO IMAGING
  • GUERBET
  • LANTHEUS
  • 第一三共
  • UNIJULES LIFE SCIENCES
  • SPAGO NANOMEDICAL
  • J.B. CHEMICALS AND PHARMACEUTICALS
  • MAGNUS HEALTH
  • TAEJOON PHARM
  • JODAS

第15章 付録

目次
Product Code: MD 3577

"Contrast media/contrast agents market is projected to grow at a CAGR of 3.9%."

The global contrast media market is projected to reach USD 5.53 billion by 2022 from an estimated USD 4.57 billion in 2017, growing at a CAGR of 3.9% during the forecast period. The contrast media market has witnessed various advancements in products and their approvals to meet the needs of patients and radiologists worldwide. Growth in the market can primarily be attributed to factors such as increasing number of approvals for contrast agents and growing number of public & private diagnostic centers. The increasing number of research and funding activities for research of contrast agents and their applications provides immense opportunities for players in the contrast media market.

"The X-ray/CT procedures segment to hold the largest share of the market in 2017."

On the basis of modality, the market is segmented into X-ray/CT, MRI, and ultrasound procedures. In 2017, X-ray/CT procedures segment is expected to command the largest share of the global contrast media market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies.

"The cardiovascular disorders segment is projected to grow at the highest CAGR during the forecast period."

On the basis of indication, the market is categorized into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders. The cardiovascular disorders segment is expected to grow at the highest CAGR during the forecast period. Improvements in cardiac MRI procedures in cath labs, favorable reimbursement policies for contrast media used in cardiovascular diagnosis, and strong healthcare infrastructure in developed countries are some of the factors driving this segment.

"Asia Pacific to witness the highest growth during the forecast period."

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2017-2022. Factors such as increasing R&D investments and favorable demographic scenario in China, rising aging population and cancer incidence in Japan, growing investments in the Indian radiology market, and growing focus of market players & increasing government support in other APAC countries are driving the growth of the market in this region.

Break of primary participants was as mentioned below:

  • By Company Type: Tier I: 55%, Tier II: 25%, Tier III: 20%
  • By Designation: C-Level Executives: 43%, Directors: 32%, Others: 25%
  • By Region: North America: 38%, Europe: 23%, Asia Pacific : 29%, RoW: 10%

In 2017, GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France) were the leading players in the contrast media market.

Research Coverage:

The report provides a picture of the market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by type, modality, route of administration, indication, application, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater share of the concerned market. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the contrast media market. The report analyzes the market on the basis of type, route of administration, modality, indication, and application
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, product approvals, and new product launches in the contrast media/contrast agents market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various contrast media/contrast agents across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the contrast media market
  • Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the contrast media market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION

4. PREMIUM INSIGHTS

  • 4.1. CONTRAST MEDIA/CONTRAST AGENTS: MARKET OVERVIEW
  • 4.2. ASIA PACIFIC CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE
  • 4.3. GEOGRAPHIC SNAPSHOT: CONTRAST MEDIA/CONTRAST AGENTS MARKET
  • 4.4. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS, BY INDICATION
  • 4.5. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing number of public & private diagnostic centers
      • 5.2.1.2. Large number of approvals for contrast agents
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Side effects and allergic reactions associated with contrast agents
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Entry of generic contrast media products
      • 5.2.3.2. Increasing research activities for contrast agents
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Technological advancements in imaging solutions
      • 5.2.4.2. Restriction and withdrawal of linear gadolinium-based contrast agents

6. PIPELINE ASSESSMENT

  • 6.1. INTRODUCTION
  • 6.2. CLINICAL TRAILS USING CONTRAST MEDIA
  • 6.3. PRODUCT PIPELINE

7. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. IODINATED CONTRAST MEDIA
  • 7.3. GADOLINIUM-BASED CONTRAST MEDIA
  • 7.4. MICROBUBBLE CONTRAST MEDIA
  • 7.5. BARIUM-BASED CONTRAST MEDIA

8. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY

  • 8.1. INTRODUCTION
  • 8.2. X-RAY/CT
  • 8.3. MAGNETIC RESONANCE IMAGING
  • 8.4. ULTRASOUND

9. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION

  • 9.1. INTRODUCTION
  • 9.2. CARDIOVASCULAR DISORDERS
  • 9.3. CANCER
  • 9.4. GASTROINTESTINAL DISORDERS
  • 9.5. MUSCULOSKELETAL DISORDERS
  • 9.6. NEUROLOGICAL DISORDERS
  • 9.7. NEPHROLOGICAL DISORDERS

10. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION

  • 10.1. INTRODUCTION
  • 10.2. INTRAVASCULAR
  • 10.3. ORAL
  • 10.4. RECTAL
  • 10.5. OTHER ROUTES

11. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY APPLICATION

  • 11.1. INTRODUCTION
  • 11.2. RADIOLOGY
  • 11.3. INTERVENTIONAL RADIOLOGY
  • 11.4. INTERVENTIONAL CARDIOLOGY

12. GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION

  • 12.1. INTRODUCTION
  • 12.2. NORTH AMERICA
    • 12.2.1. US
    • 12.2.2. CANADA
  • 12.3. EUROPE
    • 12.3.1. GERMANY
    • 12.3.2. UK
    • 12.3.3. FRANCE
    • 12.3.4. ROE
  • 12.4. ASIA PACIFIC
    • 12.4.1. CHINA
    • 12.4.2. JAPAN
    • 12.4.3. INDIA
    • 12.4.4. ROAPAC
  • 12.5. REST OF THE WORLD

13. COMPETITIVE LANDSCAPE

  • 13.1. OVERVIEW
  • 13.2. MARKET SHARE ANALYSIS
  • 13.3. COMPETITIVE SCENARIO
    • 13.3.1. MARKET DEVELOPMENTS (REGULATORY AND PRODUCT APPROVALS)
    • 13.3.2. AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
    • 13.3.3. EXPANSIONS
    • 13.3.4. MERGERS AND ACQUISITIONS
    • 13.3.5. OTHER STRATEGIES

14. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 14.1. GE HEALTHCARE
  • 14.2. BAYER
  • 14.3. BRACCO IMAGING
  • 14.4. GUERBET
  • 14.5. LANTHEUS
  • 14.6. DAIICHI SANKYO
  • 14.7. UNIJULES LIFE SCIENCES
  • 14.8. SPAGO NANOMEDICAL
  • 14.9. J.B. CHEMICALS AND PHARMACEUTICALS
  • 14.10. MAGNUS HEALTH
  • 14.11. TAEJOON PHARM
  • 14.12. JODAS

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

15. APPENDIX

  • 15.1. INSIGHTS OF INDUSTRY EXPERTS
  • 15.2. DISCUSSION GUIDE
  • 15.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 15.5. AVAILABLE CUSTOMIZATIONS
  • 15.6. RELATED REPORTS
  • 15.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: INDICATIVE LIST OF RESEARCH STUDIES UNDERTAKEN BY RESEARCH INSTITUTES AND UNIVERSITIES
  • TABLE 2: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED FOR CONTRAST MEDIA/ CONTRAST AGENTS
  • TABLE 3: INDICATIVE LIST OF THE PRODUCT PIPELINE FOR CONTRAST MEDIA/CONTRAST AGENTS
  • TABLE 4: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: IODINATED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: GADOLINIUM-BASED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: MICROBUBBLE CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: BARIUM-BASED CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 10: X-RAY/CT CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: MRI CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: ULTRASOUND CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 14: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR CARDIOVASCULAR DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR CANCER, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR NEPHROLOGICAL DISORDERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 21: INTRAVASCULAR CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: ORAL CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 23: RECTAL CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: OTHER CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 26: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR RADIOLOGY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 27: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: CONTRAST MEDIA /CONTRAST AGENTS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 33: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 35: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 36: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 37: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 38: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 39: US: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 40: INDICATIVE LIST OF RESEARCH PROJECTS IN CANADA, 2014-2017
  • TABLE 41: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 42: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 44: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 45: CANADA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 49: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 50: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 51: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 52: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 53: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 54: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 55: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 56: GERMANY: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 57: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY , 2015-2022 (USD MILLION)
  • TABLE 58: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 60: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 61: UK: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 62: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 63: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 65: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION, 2015-2022 (USD MILLION)
  • TABLE 66: FRANCE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 67: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 68: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 69: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 70: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
  • TABLE 71: ROE: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 72: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 73: APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY , 2015-2022 (USD MILLION)
  • TABLE 74: APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 76: APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
  • TABLE 77: APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 78: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY , 2015-2022 (USD MILLION)
  • TABLE 79: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 80: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 81: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
  • TABLE 82: CHINA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 83: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 84: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 85: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 86: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
  • TABLE 87: JAPAN: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 88: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 89: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 90: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 91: INDIA: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
  • TABLE 92: APAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 93: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 94: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 95: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 96: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
  • TABLE 97: ROAPAC: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 98: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY MODALITY, 2015-2022 (USD MILLION)
  • TABLE 99: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 100: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2015-2022 (USD MILLION)
  • TABLE 101: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY INDICATION 2015-2022 (USD MILLION)
  • TABLE 102: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 103: MARKET DEVELOPMENTS (REGULATORY AND PRODUCT APPROVALS)
  • TABLE 104: AGREEMENTS, COLLABORATIONS, CONTRACTS, AND PARTNERSHIPS
  • TABLE 105: EXPANSIONS
  • TABLE 106: MERGERS AND ACQUISITIONS
  • TABLE 107: OTHER STRATEGIES

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY: GLOBAL CONTRAST MEDIA/CONTRAST AGENTS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: SAMPLING FRAME: PRIMARY RESEARCH
  • FIGURE 6: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 7: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8: DATA TRIANGULATION METHODOLOGY
  • FIGURE 9: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY MODALITY (2017)
  • FIGURE 10: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017 VS. 2022
  • FIGURE 11: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY INDICATION, 2017 VS. 2022
  • FIGURE 12: CONTRAST MEDIA/CONTRAST AGENTS MARKET ANALYSIS, BY APPLICATION, 2017 VS. 2022
  • FIGURE 13: CONTRAST MEDIA/CONTRAST AGENTS MARKET, BY TYPE, 2017 VS. 2022
  • FIGURE 14: ASIA PACIFIC IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE CONTRAST MEDIA/CONTRAST AGENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: NORTH AMERICA TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2017
  • FIGURE 16: JAPAN TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CONTRAST MEDIA/CONTRAST AGENTS MARKET (2017)
  • FIGURE 17: CHINA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 18: CARDIOVASCULAR DISORDERS TO COMMAND THE LARGEST MARKET SHARE IN 2017 AND 2022
  • FIGURE 19: X-RAY/CT TO COMMAND THE LARGEST MARKET SHARE IN 2017
  • FIGURE 20: CONTRAST MEDIA/CONTRAST AGENTS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21: CLINICAL TRIALS FOR CONTRAST MEDIA/CONTRAST AGENTS, BY PHASE (2014 ONWARDS)
  • FIGURE 22: CLINICAL TRIALS FOR CONTRAST MEDIA/CONTRAST AGENTS, BY INDICATION (2014 ONWARDS)
  • FIGURE 23: MICROBUBBLE CONTRAST MEDIA/CONTRAST AGENTS SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 24: ULTRASOUND TO REGISTER HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 25: CARDIOVASCULAR DISORDERS TO DOMINATE THE CONTRAST MEDIA/CONTRAST AGENTS MARKET IN 2017
  • FIGURE 26: INTRAVASCULAR ROUTE OF ADMINISTRATION, THE FASTEST-GROWING SEGMENT IN THE CONTRAST MEDIA /CONTRAST AGENTS MARKET
  • FIGURE 27: RADIOLOGY IS EXPECTED TO BE THE LARGEST APPLICATION SEGMENT IN THE CONTRAST MEDIA /CONTRAST AGENTS MARKET IN 2017
  • FIGURE 28: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE CONTRAST MEDIA /CONTRAST AGENTS MARKET IN 2017
  • FIGURE 29: NORTH AMERICA: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
  • FIGURE 30: PREVALENCE OF ALZHEIMER'S IN THE US, BY AGE GROUP, 2015
  • FIGURE 31: EUROPE: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
  • FIGURE 32: ASIA PACIFIC: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
  • FIGURE 33: ROW: CONTRAST MEDIA /CONTRAST AGENTS MARKET SNAPSHOT
  • FIGURE 34: GLOBAL CONTRAST MEDIA MARKET SHARE, BY KEY PLAYER, 2016
  • FIGURE 35: KEY DEVELOPMENTS OF THE PROMINENT PLAYERS IN THE CONTRAST MEDIA /CONTRAST AGENTS MARKET (2014-2017)
  • FIGURE 36: GE HEALTHCARE: COMPANY SNAPSHOT
  • FIGURE 37: BAYER: COMPANY SNAPSHOT
  • FIGURE 38: GUERBET GROUP: COMPANY SNAPSHOT
  • FIGURE 39: LANTHEUS: COMPANY SNAPSHOT
  • FIGURE 40: DAIICHI SANKYO: COMPANY SNAPSHOT
  • FIGURE 41: SPAGO NANOMEDICAL: COMPANY SNAPSHOT
  • FIGURE 42: J.B. CHEMICALS AND PHARMACEUTICALS: COMPANY SNAPSHOT
Back to Top